-
-
Overview
-
A biotechnology company located in the Greater Boston area specializes in the development of advanced lipid nanoparticle (LNP) delivery systems and self-amplifying mRNA (samRNA) platforms. Leveraging a proprietary library of more than one million molecular structures, over 60,000 ionizable lipids have been synthesized and screened using high-throughput technologies. To accelerate progress in the mRNA research community, a series of ready-to-use mouse/human T cell and CD8 T cell specific delivery LNP kits have been launched for research use only for proof-of-concept and screening mRNA constructs ex vivo (in mouse splenic cells, or in human PBMC cells), and in vivo (mouse or humanized mouse).
Please contact us at for specific academic pricing.
-
- Properties
- Applications
-
Overview
Stability of human CD8 T cell targeted LNP-mRNA generated by SV106 Delivery™ Kits.
The SV106 Delivery™ kit demonstrated robust transfection efficiency and cell-type specificity in human PBMC cells.
SV106 Delivery™ Human CD8 T cell targeted
SV106 Delivery™ Human CD8 T cell targeted
Catalog Number:
TR02556209SUN
Mfr. No.:
SV106 Delivery; SV106 Delivery PLUS
Price:
$719
Size:
Quantity:
Add to Cart: